Business Context and Reporting Period
This Form 8-K is a current report filed by Landec Corporation (not Lifecore Biomedical, Inc.) on October 15, 2015. The filing details executive employment agreements, a modification to a cash bonus plan for a retiring CEO, and the results of the Annual Meeting of Stockholders held on the same date.
Key Financial Metrics and Compensation
The filing does not provide revenue, profit, cash flow, or debt metrics. It focuses on executive compensation terms:
- CEO (Molly A. Hemmeter): Annual base salary of $475,000 plus cash incentives and equity grants.
- CFO (Gregory S. Skinner): Annual base salary of $380,000 plus cash incentives and equity grants.
- Retiring CEO (Gary Steele): Eligible for a pro-rated 2016 bonus with a target of 100% of base salary, contingent on revenue and operating income targets.
Material Changes and Governance Events
- Executive Leadership: New employment agreements were executed for the CEO and CFO, effective October 15, 2015, expiring December 31, 2018. Gary Steele retired as President and CEO on this date.
- Equity Grants: Ms. Hemmeter is scheduled to receive an option for 150,000 shares and 50,000 restricted stock units at the July 2016 Board meeting, subject to continued employment.
- Severance Provisions: Agreements include severance of 100% of base salary for termination without cause/good reason, increasing to 150% in the event of a change of control followed by such termination.
Outlook, Risks, and Voting Results
Stockholder Voting Results (October 15, 2015):
- Director Election: Five Class 2 directors were elected with significant support (approx. 85-86% "For" votes).
- Auditor Ratification: Ernst & Young LLP was ratified with 99.1% approval.
- Executive Compensation: The non-binding advisory vote on executive compensation passed with 79.1% approval.
Risks and Contingencies: The filing highlights potential financial obligations related to executive severance and accelerated equity vesting in scenarios involving termination without cause, good reason, or a change of control.
Investor Verification Checklist
- Verify the total equity grant value for Ms. Hemmeter scheduled for July 2016.
- Review the specific performance targets for revenue and operating income required for Gary Steele's pro-rated bonus.
- Confirm the total number of shares outstanding to assess the dilution impact of the new equity grants.
- Check subsequent filings for any changes to the executive team or compensation structure.